<DOC>
	<DOC>NCT02894606</DOC>
	<brief_summary>The investigators expect to better characterise B cell subpopulation and functional properties early after graft, to analyse effect of induction therapy (thymoglobulin versus basiliximab) on B cells, and to compare this B cell profiles with those obtained in our previous study in patients with chronic Antibody Mediated Rejection (cAMR)</brief_summary>
	<brief_title>Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Age &gt;18 years old Recipient of a renal allograft Patient receiving either basiliximab or thymoglobulin as in induction therapy for renal transplant Patient presenting a low immunologic risk Patient not opposed to his (her) study participation Patient participating in a clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Kidney Transplant</keyword>
	<keyword>Immunology</keyword>
</DOC>